Keebeck Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $359K | Sell |
2,840
-798
| -22% | -$101K | 0.05% | 253 |
|
|
2025
Q1 | $465K | Sell |
3,638
-1,664
| -31% | -$213K | 0.07% | 174 |
|
|
2024
Q4 | $701K | Sell |
5,302
-1,000
| -16% | -$132K | 0.1% | 146 |
|
|
2024
Q3 | $918K | Sell |
6,302
-123
| -2% | -$17.9K | 0.13% | 137 |
|
|
2024
Q2 | $882K | Hold |
6,425
| – | – | 0.13% | 139 |
|
|
2024
Q1 | $882K | Sell |
6,425
-124
| -2% | -$17K | 0.13% | 143 |
|
|
2023
Q4 | $890K | Sell |
6,549
-1,465
| -18% | -$199K | 0.15% | 135 |
|
|
2023
Q3 | $983K | Sell |
8,014
-9,387
| -54% | -$1.15M | 0.17% | 126 |
|
|
2023
Q2 | $2.21M | Hold |
17,401
| – | – | 0.3% | 82 |
|
|
2023
Q1 | $2.25M | Sell |
17,401
-78
| -0.4% | -$10.1K | 0.36% | 69 |
|
|
2022
Q4 | $2.29M | Buy |
17,479
+57
| +0.3% | +$7.48K | 0.4% | 62 |
|
|
2022
Q3 | $2.04M | Sell |
17,422
-226
| -1% | -$26.4K | 0.39% | 61 |
|
|
2022
Q2 | $2.08M | Sell |
17,648
-3,401
| -16% | -$400K | 0.4% | 64 |
|
|
2022
Q1 | $2.74M | Sell |
21,049
-36
| -0.2% | -$4.69K | 0.45% | 49 |
|
|
2021
Q4 | $3.22M | Sell |
21,085
-73
| -0.3% | -$11.1K | 0.57% | 44 |
|
|
2021
Q3 | $3.42M | Hold |
21,158
| – | – | 0.67% | 36 |
|
|
2021
Q2 | $3.46M | Buy |
21,158
+1,413
| +7% | +$231K | 0.5% | 45 |
|
|
2021
Q1 | $2.97M | Sell |
19,745
-4,217
| -18% | -$635K | 0.46% | 43 |
|
|
2020
Q4 | $3.63M | Hold |
23,962
| – | – | 0.63% | 37 |
|
|
2020
Q3 | $3.24M | Sell |
23,962
-742
| -3% | -$100K | 0.67% | 35 |
|
|
2020
Q2 | $3.38M | Buy |
24,704
+3,465
| +16% | +$474K | 1.07% | 21 |
|
|
2020
Q1 | $2.29M | Buy |
21,239
+1,919
| +10% | +$207K | 0.95% | 24 |
|
|
2019
Q4 | $2.33M | Buy |
+19,320
| New | +$2.33M | 0.74% | 31 |
|